XLON:ETX
e-Therapeutics plc Stock Company Profile
£9.75
+0 (+0%)
At Close: May 03, 2024
Information
4 Kingdom Street, Floor 4 Unit 4B Paddington Central
London W2 6BD
44 20 4551 8888
www.etherapeutics.co.uk
Industry: Biotechnology
Sector: Healthcare
Description
e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing. The company was incorporated in 2001 and is based in London, the United Kingdom.